TCRX
#4244
TScan Therapeutics, Inc. - Common Stock
0.9 0 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.17%
Monthly Change
-1.10%
6 month change
-18.18%
Year Change
-52.63%
Previous Close
0.9 2
Open
0.9 0
Low
0.9 0
High
0.9 0
Volume
4
Financials
- Market Capitalization 54.97 M
- Employee 142
- Founded 2018
- CEO N/A
- Website www.tscan.com
- Headquarter Delaware, United States
- FIGI BBG00PH1N007
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.05
Price to sales ratio
14.35
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4237 |  BOLD Boundless Bio, Inc. - Common Stock | 2.49 USD | +0.81% | +1.63% | +76.60% | +114.66% | 55.94 M USD | ||
| 4241 |  INMB INmune Bio Inc. - Common stock | 2.07 USD | 0.00% | +15.64% | +56.82% | -8.81% | 55.03 M USD | ||
| 4248 |  INKT MiNK Therapeutics, Inc. - Common Stock | 10.81 USD | -2.52% | -6.24% | -12.47% | -1.73% | 53.85 M USD | ||
| 4259 |  BYSI BeyondSpring, Inc. - Ordinary Shares | 1.28 USD | +0.79% | -14.67% | -17.95% | -41.82% | 52.63 M USD |
Frequently asked questions about TScan Therapeutics, Inc. - Common Stock
What is the TScan Therapeutics, Inc. - Common Stock stock price today?
The current price of TScan Therapeutics, Inc. - Common Stock (TCRX) is 0.9. Over the past 24 hours, the stock has changed by -2.17%. Follow the TCRX chart for real-time price dynamics.
What is the stock ticker of TScan Therapeutics, Inc. - Common Stock?
TScan Therapeutics, Inc. - Common Stock trades under the ticker TCRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is TScan Therapeutics, Inc. - Common Stock stock going up?
TCRX has changed by -15.09% over the last week, -1.10% over the last month, and -52.63% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was TScan Therapeutics, Inc. - Common Stock net income for the last quarter?
TScan Therapeutics, Inc. - Common Stock reported net income of -28.67 M for the last quarter. The previous quarter showed -22.98 M, which means net income changed by -24.76%.
How many employees does TScan Therapeutics, Inc. - Common Stock have?
As of the latest available data, TScan Therapeutics, Inc. - Common Stock has 142 employees. Workforce size can provide additional context about the company's scale and operations.
What is TScan Therapeutics, Inc. - Common Stock EBITDA?
TScan Therapeutics, Inc. - Common Stock EBITDA is -28.45 M, and its EBITDA margin is -2 896.74%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy TScan Therapeutics, Inc. - Common Stock stock?
You can buy TScan Therapeutics, Inc. - Common Stock (TCRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in TScan Therapeutics, Inc. - Common Stock stock?
Investing in TScan Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TCRX chart and related analysis on metatrader.com as part of your research.